Calcium carbonate
Identification
- Summary
Calcium carbonate is an ionic compound used as a calcium supplement or antacid used for the symptomatic relief of heartburn, acid indigestion, and sour stomach.
- Brand Names
- Alka-seltzer Fruit Chews, Alka-seltzer Heartburn Plus Gas Relief, Alkums, Bayer Womens, Cal Gest, Chooz, Diphen, Duo Fusion, Healthy Mama, Irospan 24/6 Kit, Magnebind 400 Rx, Meijer, Mi-acid Double Strength, Mylanta Tonight, Nutralox, Pepcid Complete, Pepto-bismol, Phazyme, Pregvit, Rolaids Advanced, Rolaids Reformulated Aug 2006, Rolaids Ultra Strength, Titralac, Titralac Plus, Tums
- Generic Name
- Calcium carbonate
- DrugBank Accession Number
- DB06724
- Background
Calcium carbonate is an inorganic salt used as an antacid. It is a basic compound that acts by neutralizing hydrochloric acid in gastric secretions. Subsequent increases in pH may inhibit the action of pepsin. An increase in bicarbonate ions and prostaglandins may also confer cytoprotective effects. Calcium carbonate may also be used as a nutritional supplement or to treat hypocalcemia.
- Type
- Small Molecule
- Groups
- Approved, Investigational
- Structure
- Weight
- Average: 100.087
Monoisotopic: 99.947335021 - Chemical Formula
- CCaO3
- Synonyms
- Calcio carbonato
- Calcium carbonate
- Calcium carbonate (1:1)
- Calciumcarbonat
- Carbonate de calcium
- Carbonato de calcio
- Carbonic acid calcium salt (1:1)
- Chalk
- Kalziumkarbonat
- Kohlensaurer kalk
- Precipitated calcium carbonate
- External IDs
- CI 77220
- E 170
- E-170(I)
- INS NO.170(I)
- INS-170(I)
- NDI 443
Pharmacology
- Indication
For relief of heartburn and acid indigestion. May also be used as a nutritional supplement or to treat hypocalcemia.
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Conditions
Indication Type Indication Combined Product Details Approval Level Age Group Patient Characteristics Dose Form Used in combination to treat Acid reflux Combination Product in combination with: Simethicone (DB09512) ••• ••• •••••• Symptomatic treatment of Acid indigestion ••• ••• Used in combination to treat Bloating Combination Product in combination with: Simethicone (DB09512) ••• ••• •••••• Used in combination to treat Calcium deficiency Combination Product in combination with: Cholecalciferol (DB00169), Calcium lactate gluconate (DB13365) ••• ••• ••••••• •••••••••••• Used in combination to treat Calcium deficiency Combination Product in combination with: Calcium lactate (DB13231), Calcium gluconate (DB11126) ••• ••• ••••••• •••••••••••• - Associated Therapies
- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Gastric-peptic disease occurs as a result of an imbalance between protective factors, such as mucus, bicarbonate, and prostaglandin secretion, and aggressive factors, such as hydrochloric acid, pepsin, and Helicobacter pylori (H. pylori). Antacids work by restoring acid-base balance, attenuating the pepsin activity and increasing bicarbonate and prostaglandin secretion. The acid-neutralizing capacity of calcium carbonate is 58 mEq/15 ml. When used as a nutritional supplement, calcium carbonate acts by directly increasing calcium stores within the body.
- Mechanism of action
Calcium carbonate is a basic inorganic salt that acts by neutralizing hydrochloric acid in gastric secretions. It also inhibits the action of pepsin by increasing the pH and via adsorption. Cytoprotective effects may occur through increases in bicarbonate ion (HCO3-) and prostaglandins. Neutralization of hydrochloric acid results in the formation of calcium chloride, carbon dioxide and water. Approximately 90% of calcium chloride is converted to insoluble calcium salts (e.g. calcium carbonate and calcium phosphate).
- Absorption
Maximal absorption occurs at doses of 500 mg or less taken with food. Oral bioavailability depends on intestinal pH, the presence of food and dosage.
- Volume of distribution
Calcium is rapidly distributed taken up by skeletal tissues following absorption and distribution into extracellular fluids. Bone contains 99% of the body's calcium and the remaining 1% is approximately equally distributed between intracellular and extracellular fluids.
- Protein binding
Calcium acts as a co-factor to numerous enzymes.
- Metabolism
None.
- Route of elimination
Excreted mainly in the feces. The majority of renally filtered calcium is reabsorbed in the ascending limb of the loop of Henle and the proximal and distal convoluted tubules. Also secreted by sweat glands.
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs Browse all" title="About SNP Mediated Effects/ADRs" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">
- Not Available
Interactions
- Drug Interactions Learn More" title="About Drug Interactions" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Drug Interaction Integrate drug-drug
interactions in your softwareAcebutolol The therapeutic efficacy of Acebutolol can be decreased when used in combination with Calcium carbonate. Acetaminophen Calcium carbonate can cause a decrease in the absorption of Acetaminophen resulting in a reduced serum concentration and potentially a decrease in efficacy. Acetophenazine Calcium carbonate can cause a decrease in the absorption of Acetophenazine resulting in a reduced serum concentration and potentially a decrease in efficacy. Acetyldigitoxin Calcium carbonate may increase the arrhythmogenic and cardiotoxic activities of Acetyldigitoxin. Alfacalcidol The risk or severity of adverse effects can be increased when Alfacalcidol is combined with Calcium carbonate. - Food Interactions
- Take with or without food. Food increases the absorption of calcium carbonate, which may be advantageous in its use as a calcium supplement.
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- Active Moieties
Name Kind UNII CAS InChI Key Calcium unknown SY7Q814VUP 7440-70-2 OYPRJOBELJOOCE-UHFFFAOYSA-N Carbonate ion ionic 7UJQ5OPE7D 3812-32-6 BVKZGUZCCUSVTD-UHFFFAOYSA-L Calcium cation ionic 2M83C4R6ZB 14127-61-8 BHPQYMZQTOCNFJ-UHFFFAOYSA-N - Product Images
- Over the Counter Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image 7 Select Antacid Tablet, chewable 750 mg/1 Oral 7-Eleven 2014-09-11 2020-05-01 US AI kungang Liquid 55 g/100mL Topical TheJoenSpace Co,. LTD 2021-04-14 Not applicable US Alka Seltzer Tablet, chewable 750 mg/1 Oral Bestco, Inc. 2013-02-08 Not applicable US Alka-Seltzer Cool Action Extra Strength ReliefChews Mint Tablet, chewable 750 mg/1 Oral Bayer Healthcare Llc. 2019-03-03 Not applicable US Alka-Seltzer Cool Action Heartburn Relief Mint Gum, chewing 750 mg/1 Oral Bayer Healthcare Llc. 2020-03-01 Not applicable US - Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image 28tak Gum Care Tooth Calcium carbonate (36.0 g/120g) + Alcloxa (0.12 g/120g) + Aminocaproic acid (0.12 g/120g) + Calcium phosphate, dibasic (0.12 g/120g) Paste, dentifrice Oral Elmeditec Co.,Ltd 2018-07-01 Not applicable US 4240 First Aid Kit Calcium carbonate (420 mg/1) + Acetaminophen (325 mg/1) + Acetylsalicylic acid (325 mg/1) + Ammonia (0.045 g/0.3mL) + Bacitracin zinc (400 [iU]/1g) + Benzalkonium chloride (1.3 mg/1mL) + Benzethonium chloride (0.2 g/100g) + Benzethonium chloride (0.2 g/100g) + Benzocaine (10 g/100g) + Benzocaine (10 g/100g) + Isopropyl alcohol (0.7 mL/1mL) + Menthol (0.33 g/100g) + Neomycin sulfate (3.5 mg/1g) + Polymyxin B sulfate (5000 [iU]/1g) + Water (98.6 mL/100mL) Kit Ophthalmic; Oral; Respiratory (inhalation); Topical Honeywell Safety Products USA, Inc 2018-10-18 Not applicable US 4248 First Aid Kit Calcium carbonate (420 mg/1) + Acetaminophen (325 mg/1) + Acetaminophen (110 mg/1) + Acetylsalicylic acid (162 mg/1) + Ammonia (0.045 g/0.3mL) + Bacitracin zinc (400 [iU]/1g) + Benzalkonium chloride (1.3 mg/1mL) + Benzethonium chloride (0.2 g/100g) + Benzethonium chloride (0.2 g/100g) + Benzocaine (10 g/100g) + Benzocaine (10 g/100g) + Caffeine (32.4 mg/1) + Ethanol (0.5 mL/1mL) + Hydrocortisone acetate (1 g/100g) + Hydrocortisone acetate (1 g/100g) + Isopropyl alcohol (0.7 mL/1mL) + Lidocaine hydrochloride (20 mg/1mL) + Menthol (0.33 g/100g) + Neomycin sulfate (3.5 mg/1g) + Phenylephrine hydrochloride (5 mg/1) + Polymyxin B sulfate (5000 [iU]/1g) + Salicylamide (152 mg/1) + Tetrahydrozoline hydrochloride (0.05 g/100mL) + Water (98.6 mL/100mL) Kit Ophthalmic; Oral; Respiratory (inhalation); Topical Honeywell Safety Products USA, Inc 2018-10-18 Not applicable US 4327 First Aid Kit Calcium carbonate (420 mg/1) + Acetaminophen (325 mg/1) + Ammonia (0.045 g/0.3mL) + Benzalkonium chloride (0.13 g/100g) + Benzalkonium chloride (1.3 mg/1mL) + Ethanol (0.5 mL/1mL) + Lidocaine hydrochloride (20 mg/1mL) + Lidocaine hydrochloride (0.5 g/100g) + Neomycin sulfate (3.5 mg/1g) + Water (98.6 mL/100mL) Kit Ophthalmic; Oral; Respiratory (inhalation); Topical Honeywell Safety Products USA, Inc 2018-10-18 Not applicable US 4329 First Aid Kit Calcium carbonate (420 mg/1) + Acetaminophen (500 mg/1) + Ammonia (0.045 g/0.3mL) + Bacitracin zinc (400 [iU]/1g) + Benzalkonium chloride (1.3 mg/1mL) + Benzalkonium chloride (0.13 g/100g) + Benzethonium chloride (0.2 g/100g) + Benzethonium chloride (0.2 g/100g) + Benzocaine (10 g/100g) + Benzocaine (10 g/100g) + Isopropyl alcohol (0.7 mL/1mL) + Lidocaine hydrochloride (0.5 g/100g) + Menthol (0.33 g/100g) + Neomycin sulfate (3.5 mg/1g) + Polymyxin B sulfate (5000 [iU]/1g) + Water (98.6 mL/100mL) Kit Ophthalmic; Oral; Respiratory (inhalation); Topical Honeywell Safety Products USA, Inc 2018-10-18 Not applicable US - Unapproved/Other Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image 28tak Gum Care Tooth Calcium carbonate (36.0 g/120g) + Alcloxa (0.12 g/120g) + Aminocaproic acid (0.12 g/120g) + Calcium phosphate, dibasic (0.12 g/120g) Paste, dentifrice Oral Elmeditec Co.,Ltd 2018-07-01 Not applicable US 4240 First Aid Kit Calcium carbonate (420 mg/1) + Acetaminophen (325 mg/1) + Acetylsalicylic acid (325 mg/1) + Ammonia (0.045 g/0.3mL) + Bacitracin zinc (400 [iU]/1g) + Benzalkonium chloride (1.3 mg/1mL) + Benzethonium chloride (0.2 g/100g) + Benzethonium chloride (0.2 g/100g) + Benzocaine (10 g/100g) + Benzocaine (10 g/100g) + Isopropyl alcohol (0.7 mL/1mL) + Menthol (0.33 g/100g) + Neomycin sulfate (3.5 mg/1g) + Polymyxin B sulfate (5000 [iU]/1g) + Water (98.6 mL/100mL) Kit Ophthalmic; Oral; Respiratory (inhalation); Topical Honeywell Safety Products USA, Inc 2018-10-18 Not applicable US 4248 First Aid Kit Calcium carbonate (420 mg/1) + Acetaminophen (325 mg/1) + Acetaminophen (110 mg/1) + Acetylsalicylic acid (162 mg/1) + Ammonia (0.045 g/0.3mL) + Bacitracin zinc (400 [iU]/1g) + Benzalkonium chloride (1.3 mg/1mL) + Benzethonium chloride (0.2 g/100g) + Benzethonium chloride (0.2 g/100g) + Benzocaine (10 g/100g) + Benzocaine (10 g/100g) + Caffeine (32.4 mg/1) + Ethanol (0.5 mL/1mL) + Hydrocortisone acetate (1 g/100g) + Hydrocortisone acetate (1 g/100g) + Isopropyl alcohol (0.7 mL/1mL) + Lidocaine hydrochloride (20 mg/1mL) + Menthol (0.33 g/100g) + Neomycin sulfate (3.5 mg/1g) + Phenylephrine hydrochloride (5 mg/1) + Polymyxin B sulfate (5000 [iU]/1g) + Salicylamide (152 mg/1) + Tetrahydrozoline hydrochloride (0.05 g/100mL) + Water (98.6 mL/100mL) Kit Ophthalmic; Oral; Respiratory (inhalation); Topical Honeywell Safety Products USA, Inc 2018-10-18 Not applicable US 4327 First Aid Kit Calcium carbonate (420 mg/1) + Acetaminophen (325 mg/1) + Ammonia (0.045 g/0.3mL) + Benzalkonium chloride (0.13 g/100g) + Benzalkonium chloride (1.3 mg/1mL) + Ethanol (0.5 mL/1mL) + Lidocaine hydrochloride (20 mg/1mL) + Lidocaine hydrochloride (0.5 g/100g) + Neomycin sulfate (3.5 mg/1g) + Water (98.6 mL/100mL) Kit Ophthalmic; Oral; Respiratory (inhalation); Topical Honeywell Safety Products USA, Inc 2018-10-18 Not applicable US 4329 First Aid Kit Calcium carbonate (420 mg/1) + Acetaminophen (500 mg/1) + Ammonia (0.045 g/0.3mL) + Bacitracin zinc (400 [iU]/1g) + Benzalkonium chloride (1.3 mg/1mL) + Benzalkonium chloride (0.13 g/100g) + Benzethonium chloride (0.2 g/100g) + Benzethonium chloride (0.2 g/100g) + Benzocaine (10 g/100g) + Benzocaine (10 g/100g) + Isopropyl alcohol (0.7 mL/1mL) + Lidocaine hydrochloride (0.5 g/100g) + Menthol (0.33 g/100g) + Neomycin sulfate (3.5 mg/1g) + Polymyxin B sulfate (5000 [iU]/1g) + Water (98.6 mL/100mL) Kit Ophthalmic; Oral; Respiratory (inhalation); Topical Honeywell Safety Products USA, Inc 2018-10-18 Not applicable US
Categories
- ATC Codes
- A02AC01 — Calcium carbonate
- A02AC — Calcium compounds
- A02A — ANTACIDS
- A02 — DRUGS FOR ACID RELATED DISORDERS
- A — ALIMENTARY TRACT AND METABOLISM
- Drug Categories
- Alimentary Tract and Metabolism
- Antacids
- Antacids and Adsorbents
- Calcium Compounds
- Calcium Salts
- Carbon Compounds, Inorganic
- Carbonates
- Carbonic Acid
- Drugs for Acid Related Disorders
- Gastric Acid Lowering Agents
- Gastrointestinal Agents
- Mineral Supplements
- Minerals
- Polyvalent cation containing laxatives, antacids, oral supplements
- Replacement Preparations
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as organic carbonic acids. These are compounds comprising the carbonic acid functional group.
- Kingdom
- Organic compounds
- Super Class
- Organic acids and derivatives
- Class
- Organic carbonic acids and derivatives
- Sub Class
- Organic carbonic acids
- Direct Parent
- Organic carbonic acids
- Alternative Parents
- Carbonate salts / Organic calcium salts / Organic oxides / Hydrocarbon derivatives / Carbonyl compounds
- Substituents
- Aliphatic acyclic compound / Carbonate salt / Carbonic acid / Carbonyl group / Hydrocarbon derivative / Organic calcium salt / Organic oxide / Organic oxygen compound / Organic salt / Organooxygen compound
- Molecular Framework
- Aliphatic acyclic compounds
- External Descriptors
- calcium salt, one-carbon compound, carbonate salt (CHEBI:3311)
- Affected organisms
- Humans and other mammals
Chemical Identifiers
- UNII
- H0G9379FGK
- CAS number
- 471-34-1
- InChI Key
- VTYYLEPIZMXCLO-UHFFFAOYSA-L
- InChI
- InChI=1S/CH2O3.Ca/c2-1(3)4;/h(H2,2,3,4);/q;+2/p-2
- IUPAC Name
- calcium carbonate
- SMILES
- [Ca++].[O-]C([O-])=O
References
- Synthesis Reference
Nobuo Someya, Tadao Kitazato, Takao Fujikawa, Yasuo Manabe, "Sintered body of calcium carbonate and process for producing same." U.S. Patent US5187125, issued May, 1940.
US5187125- General References
- Cruz Verde: Caprimida D (calcium citrate/vitamin D) [Link]
- External Links
- KEGG Drug
- D00932
- KEGG Compound
- C08129
- PubChem Compound
- 10112
- PubChem Substance
- 310264878
- ChemSpider
- 9708
- 1897
- ChEBI
- 3311
- ChEMBL
- CHEMBL1200539
- PharmGKB
- PA448726
- Wikipedia
- Calcium_carbonate
Clinical Trials
- Clinical Trials Learn More" title="About Clinical Trials" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">
Phase Status Purpose Conditions Count 4 Completed Prevention Benign Paroxysmal Positional Vertigo (BPPV) 1 4 Completed Treatment Cardiovascular Events / Hemodialysis Treatment / Hyperphosphataemia 1 4 Completed Treatment Chronic Hepatitis, B Virus / Parathyroid Hormone / Tenofovir Disoproxil Fumarate / Vitamin D 1 4 Completed Treatment Chronic Hypoparathyroidism 1 4 Completed Treatment Chronic Kidney Disease (CKD) / Complication of Hemodialysis / Hyperphosphataemia 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Paste, dentifrice Oral Kit Ophthalmic; Oral; Respiratory (inhalation); Topical Kit; liquid; ointment; spray; tablet Ophthalmic; Oral; Topical Tablet, chewable Buccal 500 mg Granule, effervescent; kit; tablet Oral Kit Oral Tablet, chewable Buccal 100 mg Liquid Topical 55 g/100mL Gum, chewing Oral 750 mg/1 Tablet Oral 1000 mg/1 Tablet Oral 500 mg/1 Tablet Oral 750 mg/1 Tablet, chewable Oral 1000 mg/1 Tablet, chewable Oral 750 1/1 Lozenge Oral 750 mg/1 Paste Dental 36.4 g/130g Paste, dentifrice Dental 0.1 g/100g Injection, solution Parenteral Powder, for solution Oral Tablet Oral 53 mg/1001 Tablet, chewable Oral 500 mg/1 Granule Oral Tablet, effervescent Oral 1 G Tablet, effervescent Oral 1000 mg/1 Tablet, effervescent Oral 500 mg/1 Tablet Oral 600 mg/1 Tablet, effervescent Oral Tablet Oral 600 mg / tab Tablet Oral 650 mg / tab Capsule Oral 400 mg / cap Powder Oral 1 g/1g Suspension Oral 1250 mg/5mL Tablet Oral 1250 mg/1 Tablet Oral 648 mg/1 Tablet Oral 246 mg / tab Tablet Oral 1.5 g / tab Tablet Oral 1.5 g Tablet, coated Oral 500 mg Tablet Oral 625 mg / tab Tablet Oral 1.25 g / tab Tablet Oral 420 mg Capsule Oral 500 mg Tablet Oral 600.000 mg Tablet, coated Oral 600 m Granule, effervescent Oral 2500 MG Tablet, film coated Oral 500 mg/1 Tablet, effervescent Oral 240 mg Tablet, effervescent Oral 24000000 mg Liquid Topical 3 mg/100mL Tablet, chewable Oral 1177 mg/1 Tablet Oral 266.7 mg Gum, chewing Oral 500 mg/1 Tablet Oral 45 mg/1001 Tablet Oral 45 mg/1 Powder Oral 216.7 mg / g Tablet Oral 10 mg/1001 Granule Oral 750 mg/1g Capsule Oral 500 mg / cap Cream; kit; liquid; ointment; tablet; tablet, chewable; tablet, film coated Oral; Topical Tablet, chewable Buccal 470 mg Paste Oral 0.22 g/100g Tablet Oral 500 mg Tablet, effervescent Oral 500 mg Tablet, effervescent Oral Tablet Buccal Drug delivery system Oral Tablet Oral 300 mg / tab Paste, dentifrice Topical Liquid Oral 1250 mg/40mL Solution Oral 1250 mg/34mL Paste, dentifrice Topical 38.0 g/100g Powder, dentifrice Oral Tablet, chewable Buccal Gel Oral Suspension Oral 325 MG/10ML Tablet, chewable Oral 187.5 MG Suspension Oral 160 MG/10ML Tablet, chewable Oral 80 MG Tablet, chewable Buccal 750 mg Suspension Oral Capsule, delayed release Oral Tablet, chewable Oral Powder Oral 1000 mg/1 Tablet, coated Oral 150 mcg Tablet, film coated Oral 600 mg/1 Paste Oral Tablet, chewable Oral 350 mg/492mg Paste Dental 30 g/100g Tablet, coated Oral Paste, dentifrice Dental 31.25 g/100g Kit; tablet; tablet, film coated Oral Paste, dentifrice Dental 40 g/100g Granule, effervescent Oral Capsule, coated Oral Tablet Oral 56 mg/1001 Syrup Oral 1.25 g Liquid; tablet Oral Suspension Tablet Transmucosal Capsule Oral Tablet, chewable Oral Tablet, chewable Oral 420 1/1 Liquid Oral Tablet Oral 63 mg/1001 Paste Dental Capsule, gelatin coated; kit; tablet Oral Kit; tablet Oral Tablet Oral 64 mg/1001 Paste Dental 51 g/150g Powder Oral Tablet, chewable Oral 600 mg Tablet Oral 250 mg / tab Tablet Oral 250 mg Tablet, film coated Oral 400 mg Tablet, coated Oral 500 mg/1 Tablet, chewable Oral 400 mg/1 Suspension Oral 8 g Tablet Oral 400 mg Tablet, chewable Oral 420 mg/1 Tablet, film coated Oral Capsule, liquid filled; kit; tablet Oral Capsule, gelatin coated Oral Pill Oral Liquid Topical Tablet, film coated Oral 500 mg Tablet Oral Wafer Oral Tablet Oral 200 mg / tab Tablet Oral Tablet, chewable Oral 800 mg Tablet Oral 680 mg Tablet, orally disintegrating Oral Bar, chewable Oral 1177 mg/1 Lozenge Oral Bar, chewable Oral Gel, dentifrice Oral Powder Topical Cream Rectal Tablet, chewable Oral 648 mg/1 Powder Topical Paste, dentifrice Dental 15.85 g/100g Paste, dentifrice Dental Tablet, chewable Oral 750 mg/1 Tablet, extended release Oral Kit; tablet; tablet, coated Oral Kit Oral 4 g/237mL Powder, for solution Oral 4 g/237mL Tablet Oral 420 mg/1 Tablet Oral 420 mg / tab Capsule; kit; tablet, film coated Oral Lozenge Oral 200 mg/7g Tablet Oral 500.000 mg Tablet Oral 500 mg / tab Tablet Oral 750 mg Tablet Oral 750 mg / tab Tablet Oral 500.02 mg Tablet Oral 400 mg / tab Liquid Oral 400 mg / tsp Cream Oral Capsule; kit; tablet Oral Capsule, liquid filled Oral Kit; tablet, chewable Oral; Topical Tablet, film coated Oral 600 mg Capsule Oral 350 mg Tablet, film coated Oral 1000 mg Capsule Oral 835 mg Tablet Oral 1000 mg Tablet Oral 600 mg Tablet, coated Oral 350 mg Tablet, coated Oral 835 mg Tablet, film coated Oral 1500 mg Tablet, chewable Oral 1000 mg Tablet, film coated Oral 1250 mg Tablet, film coated Tablet Oral 350 mg Lotion Powder Tablet, chewable Oral 750 mg Tablet, effervescent Oral 1250 mg Tablet, chewable Oral 1250 mg Tablet, chewable Oral 1500 mg Tablet Oral 650 mg Tablet, chewable Oral 500 mg Capsule Oral 625 mg Tablet Oral 1250 mg Tablet, coated Oral 625 mg Tablet, coated Oral 1000 mg Tablet, coated Oral 1250 mg Tablet, effervescent Tablet Oral 835 mg Tablet, coated Oral 600 mg Tablet, effervescent Oral 1000 mg Tablet Tablet Oral 1500 mg - Prices
- Not Available
- Patents
Patent Number Pediatric Extension Approved Expires (estimated) Region US6814978 Yes 2004-11-09 2022-02-26 US US6165513 Yes 2000-12-26 2018-12-10 US US5994329 Yes 1999-11-30 2019-01-17 US US6015801 Yes 2000-01-18 2019-01-17 US US6432932 Yes 2002-08-13 2019-01-17 US US6465443 Yes 2002-10-15 2019-02-14 US US5989588 Yes 1999-11-23 2018-03-30 US
Properties
- State
- Solid
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 128.0 mg/mL ALOGPS logP 0.47 ALOGPS logP 0.25 Chemaxon logS -0.08 ALOGPS pKa (Strongest Acidic) 3.5 Chemaxon Physiological Charge -1 Chemaxon Hydrogen Acceptor Count 3 Chemaxon Hydrogen Donor Count 0 Chemaxon Polar Surface Area 63.19 Å2 Chemaxon Rotatable Bond Count 0 Chemaxon Refractivity 31.17 m3·mol-1 Chemaxon Polarizability 3.52 Å3 Chemaxon Number of Rings 0 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted GC-MS Spectrum - GC-MS Predicted GC-MS splash10-0002-9000000000-155f3b1435b7efbb0e7b - Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 107.48482 predictedDeepCCS 1.0 (2019) [M+H]+ 109.512405 predictedDeepCCS 1.0 (2019) [M+Na]+ 117.703636 predictedDeepCCS 1.0 (2019)
Drug created at August 09, 2010 17:35 / Updated at February 20, 2024 23:55